STAT Plus: A would-be chain of cancer centers wants to treat patients with Right to Try drugs, raising ethical questions
In an unusual move, a private equity firm is soliciting investors to help create a chain of cancer centers that would focus on providing experimental medicines that are available under the controversial Right to Try law that went into effect two years ago.
Earlier this month, Vivaris Capital began touting United Cancer Centers, which is described as the “first institutional health care system” in the U.S. to offer “integrative cancer care.” A big selling point for patients will be helping patients obtain medicines under the Right to Try law, which largely cuts the Food and Drug Administration out of the process for determining when dying patients can access experimental drugs being studied in clinical trials.
Continue to STAT Plus to read the full story…
